Corrigendum to: Bone marrow mesenchymal stem cells relieve rheumatoid arthritis by blocking JAK/STAT and TLR-4/NF-κB pathways

Shilin Lian

Open source

DOI
10.36721/pjps.2026.39.12.15945-corrigendum.1
Published
2026-09-21
Container
Pakistan Journal of Pharmaceutical Sciences
Publisher
Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36721/pjps.2026.39.12.15945-corrigendum.1,
  title = {Corrigendum to: Bone marrow mesenchymal stem cells relieve rheumatoid arthritis by blocking JAK/STAT and TLR-4/NF-κB pathways},
  author = {Shilin Lian},
  year = {2026},
  journal = {Pakistan Journal of Pharmaceutical Sciences},
  doi = {10.36721/pjps.2026.39.12.15945-corrigendum.1},
  url = {https://doi.org/10.36721/pjps.2026.39.12.15945-corrigendum.1}
}

RIS

TY  - JOUR
TI  - Corrigendum to: Bone marrow mesenchymal stem cells relieve rheumatoid arthritis by blocking JAK/STAT and TLR-4/NF-κB pathways
AU  - Shilin Lian
PY  - 2026
JO  - Pakistan Journal of Pharmaceutical Sciences
DO  - 10.36721/pjps.2026.39.12.15945-corrigendum.1
UR  - https://doi.org/10.36721/pjps.2026.39.12.15945-corrigendum.1
ER  - 

APA

Lian, S. (2026). Corrigendum to: Bone marrow mesenchymal stem cells relieve rheumatoid arthritis by blocking JAK/STAT and TLR-4/NF-κB pathways. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps.2026.39.12.15945-corrigendum.1

Source records